Replies to post #16193 on DNAprint Genomics (DNAG)

[worktoplay]

Cosmic...

From the Moffitt Agreement:

3. FUNDING - Neither Party is obligated to fund the research of the other Party. Hence, Company and Moffitt shall each be responsible for their own expenses incurred in the performance of the Projects, unless otherwise agreed to in writing. Moffitt makes no representations that they will fund any clinical trials that may ensue from the Projects. Funding for the clinical trials will be dependent upon each Principal Investigator's ability to financially support such trials and or support from Company or another third party.

Funding for the research itself is on Moffitt and DNAPrint. The trials, however, are the responsibility of the Principal Investigator along with "support" from the Company or another third party (a pharma company perhaps?) if necessary.

Should be some interesting PR's coming out over the next month...

Later,
W2P

[Gcbr]

>>BTW, Moffitt won't be doing the trials for us...they will be >>doing the trials along with us....

Robert

I stand corrected. I think this is BIG! The one thing I was
worried about was paying for the trials. It looks to me like
Moffitt has seen enough of DNAP to think that they have something they can use. Yes they have a deal with DNAP but to
take this many drugs to trial is way more than I was expecting.
The doom and gloom boys can say what they want but I think this is BIG! I know I am a dreamer---thats fine with me---I
like it that way. For me today was not a wash---we won.

Take Care
Arch